Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Hercules Capital

This Stock Is Tripling on a Key Gene Therapy Win. Should You Buy the 200%-Plus Surge Now?

Uniqure shares skyrocket as the biotech firm announces a major breakthrough in Huntington’s disease. Here’s why investors should wait before initiating a new position in QURE stock.

Stocks To Watch: Hercules Capital Sees Relative Strength Rating Jump To 82

Stocks To Watch: Hercules Capital Sees Relative Strength Rating Jump To 82

Hercules Capital shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82.

Investors Business Daily

5 High-Yield Stocks Wall Street Insiders Can’t Stop Buying

5 High-Yield Stocks Wall Street Insiders Can’t Stop Buying

BDCs offer strong returns but require caution. Experts suggest diversifying with 4-5 issuers. Five top-rated BDCs have analyst buy ratings and growth potential.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

IBD Rating Upgrades: Hercules Capital Flashes Improved Technical Strength

A Relative Strength Rating upgrade for Hercules Capital shows improving technical performance. Will it continue?

Investors Business Daily

Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report

Clinical-stage psychedelics company ATAI Life Sciences N.V. (NASDAQ: ATAI) announced its financial results for the quarter ended June 30, 2022 and business updates, including a term loan facility agreement for up to $175 million provided by Hercules Capital Inc.

What 4 Analyst Ratings Have To Say About Hercules Capital

Analysts have provided the following ratings for Hercules Capital (NYSE:HTGC) within the last quarter:

Akero Therapeutics Shares Surge After Equity Investment From This Famed Large Cap Biopharma

Akero Therapeutics Inc (NASDAQ:AKRO) announced a $25 million equity investment by Pfizer Inc (NYSE:PFE) at $9.90 per share. The company also announced a term loan facility providing Akero with access to up to $100 million from Hercules Capital Inc (NYSE:HTGC), of which $10 million will be drawn at transaction close. Together with existing cash, proceeds will support…

inkl

Read news from The Economist, FT, and more,
with one subscription

Expert Ratings for Hercules Capital

Expert Ratings for Hercules Capital

Over the past 3 months, 4 analysts have published their opinion on Hercules Capital (NYSE:HTGC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2022

The 5 Best BDC Stocks to Buy Now

The 5 Best BDC Stocks to Buy Now

Business development companies (BDCs) are a small but sky-high-yielding industry that effectively acts as private equity for the common investor.

Organisations

B of A Securities

Ollie Bargain Outlet

Evercore ISI Group

Quest Diagnostics

Zebra Technologies

Shift4 Payments

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play